Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
J Nurs Manag ; 2022 Oct 07.
Article in English | MEDLINE | ID: covidwho-2063849

ABSTRACT

AIM: The aim of this study is to explore and describe the recovery experiences of nurses working in COVID-19 wards. BACKGROUND: The global outbreak of coronavirus in 2020 has extracted job stress for nurses. Job stress has impacts on physical and mental health and performance, so recovery is essential to restore the lost energy resources. METHOD: Semi-structured interviews were conducted with 12 nurses in Isfahan city of Iran. RESULTS: The research results were extracted as 5 main themes, 14 subthemes and 54 items. The main themes are detachment from work, relaxation, non-work activities, affiliation and meaning. The combination of these themes led to the clear statement that using recovery experiences is a major step toward relieving the nurses' COVID-19-related stress and their physical and mental resuscitation. CONCLUSION: The use of recovery experiences, including detachment from work, relaxation, non-work activities, affiliation and meaning by nurses, helps them cope with job stressors and regain their resources. IMPLICATIONS FOR NURSING MANAGEMENT: It is the responsibility of health system policy makers, hospital managers and nurse managers to design and implement training programmes for nurses to use recovery experiences as stress management techniques in their profession.

2.
Life Sci ; 307: 120866, 2022 Oct 15.
Article in English | MEDLINE | ID: covidwho-2049614

ABSTRACT

Severe COVID-19 is associated with the dynamic changes in coagulation parameters. Coagulopathy is considered as a major extra-pulmonary risk factor for severity and mortality of COVID-19; patients with elevated levels of coagulation biomarkers have poorer in-hospital outcomes. Oxidative stress, alterations in the activity of cytochrome P450 enzymes, development of the cytokine storm and inflammation, endothelial dysfunction, angiotensin-converting enzyme 2 (ACE2) enzyme malfunction and renin-angiotensin system (RAS) imbalance are among other mechanisms suggested to be involved in the coagulopathy induced by severe acute respiratory syndrome coronavirus (SARS-CoV-2). The activity and function of coagulation factors are reported to have a circadian component. Melatonin, a multipotential neurohormone secreted by the pineal gland exclusively at night, regulates the cytokine system and the coagulation cascade in infections such as those caused by coronaviruses. Herein, we review the mechanisms and beneficial effects of melatonin against coagulopathy induced by SARS-CoV-2 infection.


Subject(s)
COVID-19 , Melatonin , Angiotensin-Converting Enzyme 2 , Blood Platelets/metabolism , COVID-19/complications , Cytokines/pharmacology , Humans , Melatonin/pharmacology , Melatonin/therapeutic use , Peptidyl-Dipeptidase A/metabolism , Renin-Angiotensin System , SARS-CoV-2
3.
Pharmacol Ther ; 224: 107825, 2021 08.
Article in English | MEDLINE | ID: covidwho-1117458

ABSTRACT

Coronaviruses (CoVs) are a group of single stranded RNA viruses, of which some of them such as SARS-CoV, MERS-CoV, and SARS-CoV-2 are associated with deadly worldwide human diseases. Coronavirus disease-2019 (COVID-19), a condition caused by SARS-CoV-2, results in acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) associated with high mortality in the elderly and in people with underlying comorbidities. Results from several studies suggest that CoVs localize in mitochondria and interact with mitochondrial protein translocation machinery to target their encoded products to mitochondria. Coronaviruses encode a number of proteins; this process is essential for viral replication through inhibiting degradation of viral proteins and host misfolded proteins including those in mitochondria. These viruses seem to maintain their replication by altering mitochondrial dynamics and targeting mitochondrial-associated antiviral signaling (MAVS), allowing them to evade host innate immunity. Coronaviruses infections such as COVID-19 are more severe in aging patients. Since endogenous melatonin levels are often dramatically reduced in the aged and because it is a potent anti-inflammatory agent, melatonin has been proposed to be useful in CoVs infections by altering proteasomal and mitochondrial activities. Melatonin inhibits mitochondrial fission due to its antioxidant and inhibitory effects on cytosolic calcium overload. The collective data suggests that melatonin may mediate mitochondrial adaptations through regulating both mitochondrial dynamics and biogenesis. We propose that melatonin may inhibit SARS-CoV-2-induced cell damage by regulating mitochondrial physiology.


Subject(s)
COVID-19 Drug Treatment , Melatonin/pharmacology , Mitochondria/pathology , Aged , Animals , Antioxidants/administration & dosage , Antioxidants/pharmacology , COVID-19/complications , COVID-19/virology , Coronavirus Infections/complications , Coronavirus Infections/virology , Female , Humans , Melatonin/administration & dosage , Mitochondria/drug effects , Mitochondria/virology , Severe Acute Respiratory Syndrome/complications , Severe Acute Respiratory Syndrome/virology , Virus Replication
4.
Virus Res ; 287: 198108, 2020 10 02.
Article in English | MEDLINE | ID: covidwho-694184

ABSTRACT

Viral infections are dangerous diseases for human health worldwide, which lead to significant morbidity and mortality each year. Because of their importance and the lack of effective therapeutic approaches, further attempts should be made to discover appropriate alternative or complementary treatments. Melatonin, a multifunctional neurohormone mainly synthesized and secreted by the pineal gland, plays some roles in the treatment of viral infections. Regarding a deadly outbreak of COVID-19 across the world, we decided to discuss melatonin functions against various viral infections including COVID-19. Therefore, in this review, we summarize current evidence on melatonin therapy for viral infections with focus on possible underlying mechanisms of melatonin actions.


Subject(s)
Antiviral Agents/pharmacology , Betacoronavirus/drug effects , Coronavirus Infections/virology , Melatonin/pharmacology , Pneumonia, Viral/virology , Antioxidants , Antiviral Agents/therapeutic use , COVID-19 , Coronavirus Infections/drug therapy , Coronavirus Infections/epidemiology , Coronavirus Infections/metabolism , Host-Pathogen Interactions , Humans , Melatonin/therapeutic use , Oxidative Stress/drug effects , Pandemics , Pneumonia, Viral/drug therapy , Pneumonia, Viral/epidemiology , Pneumonia, Viral/metabolism , SARS-CoV-2 , Signal Transduction/drug effects , Vaccination , Viral Vaccines/administration & dosage , Viral Vaccines/immunology , Virus Diseases/drug therapy , Virus Diseases/metabolism , Virus Diseases/virology
SELECTION OF CITATIONS
SEARCH DETAIL